Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
BM

BMY

Market Closed

Bristol-Myers Squibb Company

NYSEHealthcareDrug Manufacturers - General
US
34.10K employees
CEO: Christopher S. Boerner
Founded: 1972
$54.00
+$0.00(+NaN%)
Market Cap
110.27B
Beta
0.24
52W Range
N/A
Dividend Yield
4.63%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Bristol-Myers Squibb’s current price trades significantly below its high-confidence fair value of $152.68, indicating potential undervaluation with implied upside exceeding 170%. Strong profitability contrasts with weak leverage and growth scores, while Monte Carlo analysis shows high volatility but no downside risk below the current price. Valuation divergence suggests risk linked to leverage and growth uncertainties despite optimistic long-term value outcomes.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore BMY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BMY in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms